drugset
drugset / Trial / NCT02587975

Effect of Evogliptin on Bone Metabolism in Human

NCT02587975 ↗

Phase 4 Unknown 20 enrolled DongGuk University
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to measure the effect of evogliptin on bone metabolism in healthy volunteers.

Timeline

Start
2016-06
Primary completion
2016-11
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Evogliptin Small molecule 10 mg Oral

Indications

osteoporosis type 2 diabetes mellitus